SCHEMBL4193425

SCHEMBL4193425

COc1ccc(-c2ccc(S(=O)(=O)Nc3ccccc3CN[C@@H](C)CC3CCCCC3)s2)c(OC)c1OC

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 8/20 0.38
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
TSHR P16473 2/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
KDM4E B2RXH2 1/20 0.35
PKM P14618 1/20 0.35
CTSD P07339 1/20 0.34
PI4KB Q9UBF8 2/20 0.34
PI4KA P42356 1/20 0.33
CASP1 P29466 1/20 0.33
CASP7 P55210 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HSD17B10 Q99714 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4185866 0.99 GHSR (0.38) GHSRNPC1RAB9ATSHRALDH1A1
SCHEMBL4195284 0.88 TP53 (0.41) GHSRNPC1RAB9ATSHRALDH1A1
SCHEMBL4193037 0.88 TP53 (0.41) GHSRNPC1RAB9ATSHRALDH1A1
SCHEMBL4190359 0.87 TP53 (0.41) GHSRNPC1RAB9ATSHRALDH1A1
SCHEMBL4189890 0.86 MMP13 (0.40) GHSRNPC1RAB9ATSHRALDH1A1
SCHEMBL4195287 0.86 MMP13 (0.40) GHSRNPC1RAB9ATSHRALDH1A1
SCHEMBL4196866 0.85 MMP13 (0.41) GHSRNPC1RAB9ATSHRALDH1A1
SCHEMBL4185970 0.83 KDM4E (0.40) GHSRALDH1A1LMNAKDM4EPKM
SCHEMBL4195566 0.83 MMP13 (0.43) GHSR
SCHEMBL4197564 0.82 KDM4E (0.39) GHSRKDM4EPKMMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP claimed
US-8076370-B2 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2011-12-13 US claimed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US claimed
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP disclosed
US-8076370-B2 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2011-12-13 US disclosed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215764-A1 Antimicrobial agents TUFM, RPS17, HARS1 GHSR 3645/4885NPC1 1859/4885RAB9A 4342/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.